LISATA THERAPEUTICS, INC.: capex

Value{"amount": 118478, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2017-01-01 – 2017-09-30
Statuscurrent
EntityLISATA THERAPEUTICS, INC.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000320017-17-000093 · Open the official SEC filing →
Retrieved: 2026-08-19T07:30:03.792427+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000320017/capex/2017-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/a335a9fa-be35-4b5f-b1e6-120810a0cedd

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies